While an average of 71% of CD27−CD28− subset from CMV seropositive individuals expressed GzmB and perforin, only 18% were positive for these cytotoxic molecules in CD27−CD28−CD4+ T cells from people without CMV infection. The gene discussed is GZMB; the disease is cytomegalovirus infection.